Full-Time

Associate Director – Product Lead Business Systems

Supply Chain

Posted on 3/25/2025

AstraZeneca

AstraZeneca

10,001+ employees

Develops and commercializes prescription medicines

Compensation Overview

$112.3k - $168.4k/yr

Senior, Expert

Santa Monica, CA, USA

Category
Procurement & Sourcing
Supply Chain Management
Operations & Logistics
Required Skills
Market Research
Product Management
SAP Products
Salesforce
Requirements
  • Ten (10) years with BS/BA, or Eight (8) years with MS/MA in Life Sciences, Biotechnology, in Information Technology, Computer Science, Engineering, or a related field.
  • Minimum of 7 years of experience in product development and management, technology, clinical & commercial background, with a focus on cell therapy, biotechnology, or pharmaceuticals.
  • Experience with cell therapy processes, technologies, and market dynamics.
  • Experience with building technology with a product mindset.
  • Experience leading enterprise-wide system implementations, including cell orchestration, supply chain, commercial applications, and other operational technologies, from requirements gathering to post-implementation support.
  • Project management skills, with experience working with teams and managing complex projects in a regulated environment.
  • Translate market insights into relevant plans.
  • Present to senior leadership and external partners.
  • Proficiency in systems and technology platforms relevant to life sciences manufacturing, supply chain and commercial operations, such as ERP (SAP), Salesforce systems, cell orchestration, data management.
Responsibilities
  • Develop a comprehensive product strategy for cell orchestration, aligning technology investments with our goals and priorities.
  • Conduct market research to identify trends, opportunities, and competitive threats in the cell therapy and orchestration space.
  • Collaborate with R&D clinical, Manufacturing, Regulatory, and Commercial teams to ensure cohesive product development and patient-centric strategies.
  • Lead the cell orchestration development lifecycle, ensuring delivery and adherence to quality standards.
  • Lead change management efforts to improve adoption and use of new products and technology solutions, providing training, support, and communication to partners at all levels.
  • Engage with partners, including customers, partners, and industry experts, to gather feedback and ensure the product meets market needs.
  • Manage the product budget, forecast & actuals, and track product performance.
  • Manage relationships with technology vendors and service providers, overseeing contracts, service level agreements (SLAs), and performance to ensure understanding of our requirements and goals.
  • Ensure all product activities comply with relevant regulatory requirements and AstraZeneca's internal policies.

AstraZeneca focuses on discovering, developing, and selling prescription medicines, primarily in three areas: Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Their products are developed through extensive research and development, which includes rigorous clinical trials and regulatory approvals before reaching the market. AstraZeneca differentiates itself from competitors by investing heavily in scientific research and fostering collaborations through initiatives like their Open Innovation program, which shares resources with the scientific community to speed up drug discovery. The company's goal is to advance healthcare by creating effective treatments for serious diseases and expanding their product offerings through strategic partnerships.

Company Size

10,001+

Company Stage

IPO

Headquarters

Cambridge, United Kingdom

Founded

1913

Simplify Jobs

Simplify's Take

What believers are saying

  • AI-driven drug discovery could enhance AstraZeneca's R&D efficiency.
  • Real-world evidence supports AstraZeneca's efforts in demonstrating drug efficacy and safety.
  • Personalized medicine aligns with AstraZeneca's focus on precision medicine.

What critics are saying

  • AstraZeneca faces a class-action lawsuit over alleged Soliris monopoly practices.
  • AI tools for breast cancer screening may face challenges due to minority underrepresentation.
  • Investment in Dunkirk may be at risk due to potential regulatory changes.

What makes AstraZeneca unique

  • AstraZeneca focuses on three main therapy areas: Oncology, Cardiovascular, and Respiratory.
  • The company invests heavily in R&D to create innovative prescription medicines.
  • AstraZeneca's A.Catalyst Network fosters global collaboration and innovation in healthcare.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Flexible Work Hours

Company News

Cision
Apr 22nd, 2025
Enhertu Combination Improved Pfs In 1L Her2+ Mbc

Enhertu combination improved PFS in 1L HER2+ mBC

Life Sciences IP Review
Apr 17th, 2025
AstraZeneca unit faces class-action suit over alleged Soliris monopoly

AstraZeneca unit faces class-action suit over alleged soliris monopoly.

Our Health Needs
Apr 11th, 2025
Study: Racial, ethnic minorities are underrepresented in AI mammogram interpretation

In 2024, AI biotech company Owkin partnered with pharma giant AstraZeneca to develop an AI-powered tool designed to pre-screen for gBRCA mutations (gBRCAm) in breast cancer directly from digitized pathology slides.

Medical Update Online
Apr 11th, 2025
AstraZeneca showcases progress in immunisation and real-world evidence addressing global infectious disease burden at ESCMID Global 2025

AstraZeneca showcases progress in immunisation and real-world evidence addressing global infectious disease burden at ESCMID Global 2025.

Cision
Apr 11th, 2025
Result Of Agm

11 April 2025Results of Annual General Meeting held on 11 April 2025AstraZeneca PLC announced the results of the voting at its Annual General Meeting (AGM) today. As proposed in the Notice of AGM, all Resolutions were decided by poll vote. Resolutions 9 - 12 were passed as special resolutions; all other resolutions were passed as ordinary resolutions.Resolution. Votes for. % of votes cast

INACTIVE